Huddinge, Sweden

Li Yi-Lin

This inventor holds 1 USPTO granted patent. Top assignee: Karo Bio Ab. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li Yi-Lin. Retrieved from https://idiyas.com/inventor/li-yi-lin-48nf4sf7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Li Yi-Lin

Introduction

Li Yi-Lin is a notable inventor based in Huddinge, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the area of thyroid receptor ligands. Her work has implications for the treatment of disorders influenced by thyroid hormones.

Latest Patents

Li Yi-Lin holds a patent for "Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones." This invention relates to compounds that are selective for the thyroid hormone receptor β. The patent outlines methods for preparing these compounds and their applications in regulating metabolism.

Career Highlights

Li Yi-Lin is associated with Karo Bio AB, a company known for its innovative research in drug development. Her work at Karo Bio AB has positioned her as a key player in the pharmaceutical industry, particularly in the development of therapies targeting thyroid-related disorders.

Collaborations

Li Yi-Lin has collaborated with notable colleagues such as Johan Malm and Chris Litten. These collaborations have further enhanced her research and contributions to the field.

Conclusion

Li Yi-Lin's innovative work in the development of thyroid receptor ligands showcases her expertise and commitment to advancing pharmaceutical science. Her contributions are vital for the treatment of thyroid hormone-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…